/
LXRX
$2.34-$0.01 (-0.43%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.0B
445M shares
52-week range
$1.03 – $2.68
79% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-1.27
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
www.lexpharma.com- Employees
- 81
- IPO / List date
- Apr 7, 2000
- HQ
- THE WOODLANDS, TX
Held by traders on TradeandTell
No one on the platform currently holds LXRX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,600,500 | $2.5M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2015-05-21 | 1-for-7reverse |
Recent trades on TradeandTell
No one on the platform has traded LXRX yet.
